Russell D. Cohen, MD, FACG, AGAF - Changing the Course of Ulcerative Colitis: Addressing Unmet Needs Through Effective Disease Severity Assessments and New Therapeutic Strategies

Please visit answersincme.com/EXY860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, an expert in gastroenterology discusses the disease severity assessment and treatment of patients with moderately to severely active ulcerative colitis (UC).Upon completion of this activity, participants should be better able to: Identify appropriate strategies to effectively assess disease severity in ulcerative colitis; Describe the rationale for Janus kinase (JAK) inhibitors in targeting the disease pathophysiology in patients with ulcerative colitis; and Outline strategies to individualize the treatment selection for patients with ulcerative colitis.

There are no comments yet.

Please log in to write the first comment.